This week at SpaceX: AI bets, losses and push for control as mega IPO looms

SpaceX is preparing for a late-June IPO targeting a $1.75 trillion valuation and $75 billion in new capital, while also disclosing a $4.94 billion consolidated loss in 2025 on $18.67 billion of revenue. The company is considering a $60 billion Cursor acquisition option or a $10 billion partnership, and plans super-voting shares that would preserve Elon Musk's control after listing. The roadshow, retail allocation plans, and warnings about unproven moon/Mars and space-AI ambitions make this a major IPO and governance story with potential market implications for large-cap offerings.

Analysis

The market is increasingly treating mega-private platforms as public-market comp players, and the real catalyst here is not the IPO itself but benchmark inclusion mechanics. If index providers relax liquidity screens, passive funds become forced buyers, compressing the public float float-adjusted scarcity premium and creating a predictable technical bid in the first 1-2 quarters post-listing. That said, the governance structure is likely to be the more durable valuation support than the growth narrative: investors may accept lower cash-flow visibility if control is effectively insulated, because it reduces classic founder-succession discount.

The risk is that the IPO roadshow is trying to price two conflicting stories at once: a frontier-tech optionality story and a capital-intensive industrial story. The disclosed spending trajectory implies that every incremental dollar of AI ambition has to be financed at a time when the company is already signaling losses, so any stumble in execution could trigger a multiple reset faster than usual for a marquee name. The highest-probability reversal is not macro, but a tighter-than-expected secondary market appetite for an instrument with limited governance rights and a very large valuation gap versus current public analogs.

Second-order beneficiaries are likely to be less obvious than the stock itself. Index methodology vendors, retail brokerages, and derivative market-makers should see higher volumes and fee pools as retail access broadens across geographies and listing-day volatility rises. Conversely, public-market AI infrastructure and growth proxies could be pressured if capital is reallocated toward this single name as a quasi-must-own benchmark constituent, especially if it arrives with a valuation that forces investors to sell other long-duration tech to fund exposure.

Contrarian view: the consensus is probably overestimating how cleanly retail demand translates into stable public-market support. Retail can absorb stock on day one, but it is usually weaker at funding post-lockup supply and governance controversies, so the more important test is whether institutions accept the permanent-control structure after the novelty fades. If the first few quarters show rising losses without a clear monetization path for AI capex, the stock could trade like a scarcity asset initially and a governance discount later.

Key Decisions for Investors

• Watch MORN for a tactical long into index-rule changes over the next 1-3 months: the alternative liquidity screen can expand the addressable universe for mega-IPOs and supports incremental AUM/benchmark revenue; use weakness to build, but expect a modest multiple rerating rather than a re-rating explosion.
• Initiate a relative-value short basket of public AI infrastructure/growth proxies versus a long on any eventual SpaceX listing if available; the setup is a capital-flight trade where new scarcity capital crowds into the marquee issue and compresses weaker-duration names over 1-2 quarters.
• If listing terms include limited governance rights and a high retail allocation, buy downside protection on the IPO through put spreads 2-4 weeks after pricing; the best risk/reward is post-lockup into the first earnings update, where the market will focus on burn rate rather than narrative.
• For event-driven accounts, prepare a pair trade long MORN / short an exchange operator with heavier IPO dependence for 3-6 months: MORN benefits from methodology changes and index construction churn, while exchange economics are more exposed to one-off listing hype than recurring benchmark upgrades.
• Avoid chasing any first-day public-market proxy for the IPO at a large premium; wait for the first secondary offering or first post-listing quarter, where the valuation will better reflect whether AI capex is converting into monetizable product revenue or just enlarging the loss curve.